Last Updated:
September 11, 2026

Haemophilus influenzae type b

Overview

Hib disease is caused by the bacterium Haemophilus influenzae type b. Humans are the only host of these bacteria. Infants and children less than five years of age are most vulnerable to Hib infections. Despite the similar name, H. influenzae type b is not the same as influenza and it is not a virus. The Hib vaccine protects against type b disease; it does not protect against other types or non-typeable H influenzae.

Introduction

Hib disease was the most common cause of life-threatening bacterial infection in children under five years of age prior to introduction of the Hib vaccine in 1994. Since then, the number of children hospitalised for Hib meningitis or epiglottitis has decreased by around 90%.

However, Hib remains in circulation, and rare cases still occur, mostly in young children who are unimmunised or not fully immunised. Maintaining high immunisation coverage and giving vaccines on time are important because Hib vaccination protects vaccinated children and helps reduce Hib carriage and transmission in the community.

Transmission

clickable image of an arrow pointing down

Hib bacteria are commonly carried in the nose and throat and do not usually cause illness.

The bacteria can be transferred from person to person through contact with respiratory droplets in the air and on surfaces by coughing or sneezing, or through direct contact with respiratory secretions.

Living with pre-school and school-aged siblings, living in a crowded household or having another respiratory infection, such as seasonal influenza, can increase the chance of carrying the bacteria. Smoke exposure can also damage the respiratory tract and may increase the risk of invasive infection.

Household and other close contacts of someone with the disease, such as through intimacy, sharing food and beverages, and infants and children attending day care or an early childhood education centre, are at increased risk of disease.

Symptoms

clickable image of an arrow pointing down

Like several other diseases (e.g. pneumococcal and meningococcal disease), the symptoms and presentation of Hib will depend on where the bacteria is in the body. All three of these diseases can present as meningitis (inflammation of the membranes around the brain) or bacteraemia (infection in the bloodstream, sometimes called septicaemia or blood poisoning). However, they can present in other ways. Hib, for example may present as epiglottitis (severe swelling in the throat) or pneumonia.

Symptoms of meningitis

  • Fever, loss of appetite, vomiting
  • Drowsiness, headache, sensitivity to bright light, neck stiffness
  • Signs may be vague and non-specific in young infants; they may have a bulging fontanelle

Symptoms of epiglottitis

  • Fever
  • Breathing difficulty
  • Noisy breathing
  • Difficulty swallowing
  • Drooling

A child with epiglottitis may sit with an extended neck and their tongue sticking out to help them breathe.

Treatment

clickable image of an arrow pointing down

Children with signs of meningitis or epiglottitis should see a doctor very urgently.

Call 111 immediately if a child has difficulty breathing, is drooling and unable to swallow, is unusually drowsy or difficult to wake, or appears seriously unwell. Do not try to examine the throat of a child with suspected epiglottitis, as this may worsen airway obstruction.

Hib infection is treated with antibiotics. Supportive therapy may be required which could involve hospitalisation and intensive care.

Risks

clickable image of an arrow pointing down

After Hib bacteria passes into the blood and the person develops invasive Hib disease the risks are, for:

  • Meningitis
  • Of those who develop meningitis and survive, 20-40% will have long term neurological damage
  • One person out of every 20 infected with Hib meningitis will die despite early identification and treatment
  • Septicaemia (blood infection)
  • Epiglottitis (severe swelling in the throat) that can affect breathing
  • Pneumonia and inflammation in other organs, such as heart, joints, bones and skin

Children under 5 years of age have an increased risk of Hib disease, particularly infants and children who are not fully immunised for their age. Those aged 4 to 18 months and Māori or Pacific children aged under two years are have the greatest risk of Hib meningitis. Children aged 2-4 years have an increased risk of Hib epiglottitis.

Some people with certain medical conditions have an increased risk of infection, for example, those without a functioning spleen, and those who are immune compromised from a disease or treatment of a disease. Some people need additional Hib vaccination because of an underlying condition or treatment.

Prevention

clickable image of an arrow pointing down

Vaccination is the most effective way to prevent Hib disease. It is available and used for all infants and young children, and for older children and adults with impaired immune systems. Hib vaccination also reduces carriage and transmission, helping to protect people who are too young or unable to be fully protected by vaccination.

Other measures that may reduce spread or the risk of invasive disease include:

  • Avoid overcrowded living conditions, if possible
  • Avoid sharing food, drinks and eating utensils
  • Limit close physical contact when coughing and sneezing
  • Remember to cover your mouth and wash hands thoroughly after coughing or sneezing

Find out more about Hib vaccines, including the recommended schedule and timing, on our ACT-Hib vaccine page.

Last updated:
Sep 2026
Cartoon image of a man showing his arm where he received a vaccination

Hib disease is caused by the bacterium Haemophilus influenzae type b. Humans are the only host of these bacteria. Infants and children less than five years of age are most vulnerable to Hib infections. Despite the similar name, H. influenzae type b is not the same as influenza and it is not a virus. The Hib vaccine protects against type b disease; it does not protect against other types or non-typeable H influenzae.

Introduction

Hib disease was the most common cause of life-threatening bacterial infection in children under five years of age prior to introduction of the Hib vaccine in 1994. Since then, the number of children hospitalised for Hib meningitis or epiglottitis has decreased by around 90%.

However, Hib remains in circulation, and rare cases still occur, mostly in young children who are unimmunised or not fully immunised. Maintaining high immunisation coverage and giving vaccines on time are important because Hib vaccination protects vaccinated children and helps reduce Hib carriage and transmission in the community.

Transmission

clickable image of an arrow pointing down

Hib bacteria are commonly carried in the nose and throat and do not usually cause illness.

The bacteria can be transferred from person to person through contact with respiratory droplets in the air and on surfaces by coughing or sneezing, or through direct contact with respiratory secretions.

Living with pre-school and school-aged siblings, living in a crowded household or having another respiratory infection, such as seasonal influenza, can increase the chance of carrying the bacteria. Smoke exposure can also damage the respiratory tract and may increase the risk of invasive infection.

Household and other close contacts of someone with the disease, such as through intimacy, sharing food and beverages, and infants and children attending day care or an early childhood education centre, are at increased risk of disease.

Symptoms

clickable image of an arrow pointing down

Like several other diseases (e.g. pneumococcal and meningococcal disease), the symptoms and presentation of Hib will depend on where the bacteria is in the body. All three of these diseases can present as meningitis (inflammation of the membranes around the brain) or bacteraemia (infection in the bloodstream, sometimes called septicaemia or blood poisoning). However, they can present in other ways. Hib, for example may present as epiglottitis (severe swelling in the throat) or pneumonia.

Symptoms of meningitis

  • Fever, loss of appetite, vomiting
  • Drowsiness, headache, sensitivity to bright light, neck stiffness
  • Signs may be vague and non-specific in young infants; they may have a bulging fontanelle

Symptoms of epiglottitis

  • Fever
  • Breathing difficulty
  • Noisy breathing
  • Difficulty swallowing
  • Drooling

A child with epiglottitis may sit with an extended neck and their tongue sticking out to help them breathe.

Treatment

clickable image of an arrow pointing down

Children with signs of meningitis or epiglottitis should see a doctor very urgently.

Call 111 immediately if a child has difficulty breathing, is drooling and unable to swallow, is unusually drowsy or difficult to wake, or appears seriously unwell. Do not try to examine the throat of a child with suspected epiglottitis, as this may worsen airway obstruction.

Hib infection is treated with antibiotics. Supportive therapy may be required which could involve hospitalisation and intensive care.

Risks

clickable image of an arrow pointing down

After Hib bacteria passes into the blood and the person develops invasive Hib disease the risks are, for:

  • Meningitis
  • Of those who develop meningitis and survive, 20-40% will have long term neurological damage
  • One person out of every 20 infected with Hib meningitis will die despite early identification and treatment
  • Septicaemia (blood infection)
  • Epiglottitis (severe swelling in the throat) that can affect breathing
  • Pneumonia and inflammation in other organs, such as heart, joints, bones and skin

Children under 5 years of age have an increased risk of Hib disease, particularly infants and children who are not fully immunised for their age. Those aged 4 to 18 months and Māori or Pacific children aged under two years are have the greatest risk of Hib meningitis. Children aged 2-4 years have an increased risk of Hib epiglottitis.

Some people with certain medical conditions have an increased risk of infection, for example, those without a functioning spleen, and those who are immune compromised from a disease or treatment of a disease. Some people need additional Hib vaccination because of an underlying condition or treatment.

Prevention

clickable image of an arrow pointing down

Vaccination is the most effective way to prevent Hib disease. It is available and used for all infants and young children, and for older children and adults with impaired immune systems. Hib vaccination also reduces carriage and transmission, helping to protect people who are too young or unable to be fully protected by vaccination.

Other measures that may reduce spread or the risk of invasive disease include:

  • Avoid overcrowded living conditions, if possible
  • Avoid sharing food, drinks and eating utensils
  • Limit close physical contact when coughing and sneezing
  • Remember to cover your mouth and wash hands thoroughly after coughing or sneezing

Find out more about Hib vaccines, including the recommended schedule and timing, on our ACT-Hib vaccine page.

Last updated:
Sep 2026